{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:13:45Z","timestamp":1794262425127,"version":"4.9.0"},"reference-count":84,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T00:00:00Z","timestamp":1688256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/D\/145654\/2019"],"award-info":[{"award-number":["SFRH\/D\/145654\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\u201050006\/2020"],"award-info":[{"award-number":["UIDB\u201050006\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Fundamemntal Clinical Pharma"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The renin\u2010angiotensin system (RAS) has been associated with inflammatory bowel disease (IBD), supporting translational relevance of RAS blockers. Comparability of study design\/outcomes is fundamental for data analysis\/discussion.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed at evaluating the heterogeneity among protocols and outcomes to study the effect of angiotensin\u2010converting enzyme inhibitors or angiotensin receptor blockers in IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was performed and reported in accordance with the Cochrane recommendations and PRISMA (PROSPERO\u2010CRD42022323853). Systematic searches were performed in PubMed, Scopus and Web of Science. Studies that met the inclusion criteria were selected. Quality assessment of the studies was done with the SYRCLES's risk of bias tools for animal studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty\u2010five pre\u2010clinical studies and six clinical studies were included. Chemical induction of colitis was the most used model, but variable doses of the induction agent were reported. All studies reported at least a disease activity index, a macroscopic score, or a histologic assessment, but these scores were methodologically heterogeneous and reported for different characteristics. Great heterogeneity was also found in drug interventions. Inflammatory markers assessed as outcomes were different across studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Lack of standardization of protocols and outcomes among studies threatens the evidence on how RAS blockers influence IBD outcomes.<\/jats:p><\/jats:sec>","DOI":"10.1111\/fcp.12935","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T01:04:15Z","timestamp":1688346255000},"page":"1139-1152","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heterogeneity in protocols and outcomes to study the effect of renin\u2010angiotensin system blockers in inflammatory bowel disease: A systematic review"],"prefix":"10.1111","volume":"37","author":[{"given":"Mariana","family":"Ferreira\u2010Duarte","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences Faculty of Pharmacy, University of Porto  Porto Portugal"},{"name":"LAQV@REQUIMTE University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda S.","family":"Tonin","sequence":"additional","affiliation":[{"name":"ESTeSL\u2010Escola Superior de Tecnologia da Sa\u00fade Instituto Polit\u00e9cnico de Lisboa  Lisbon Portugal"},{"name":"H&amp;TRC\u2010Health and Technology Research Center Instituto Polit\u00e9cnico de Lisboa  Lisbon Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarida","family":"Duarte\u2010Ara\u00fajo","sequence":"additional","affiliation":[{"name":"LAQV@REQUIMTE University of Porto  Porto Portugal"},{"name":"Department of Immuno\u2010Physiology and Pharmacology, School of Medicine and Biomedical Sciences (ICBAS) University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-9595","authenticated-orcid":false,"given":"Fernando","family":"Fernandez\u2010Llimos","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences Faculty of Pharmacy, University of Porto  Porto Portugal"},{"name":"UCIBIO i4HB \u2010 Applied Molecular Biosciences Unit Faculty of Pharmacy, University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Morato","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Drug Sciences Faculty of Pharmacy, University of Porto  Porto Portugal"},{"name":"LAQV@REQUIMTE University of Porto  Porto Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2023,7,2]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102796.2008.01981.x"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748\u20101716.2006.01600.x"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00036.2005"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102036.2011.04971.x"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748\u20101716.2010.02165.x"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094836"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799436593"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev\u2010immunol\u2010030409\u2010101225"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.07.042"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468\u20101253(19)30173\u20106"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.63"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastrohep.2020.09.002"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa258"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011\u2010007\u20107098\u2010y"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1470320314521086"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13019"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmgh.2015.01.006"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.4997\/jrcpe.2020.409"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_2_12_21_1","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions, version 6.3 (updated 2022)","author":"Higgins JPT","year":"2022"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u20102288\u201014\u201043"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2008.03.043"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00264.2009"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010011\u20101651\u20109"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010006\u20109124\u20102"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010013\u20102825\u20104"},{"issue":"4","key":"e_1_2_12_28_1","article-title":"Angiotensin II type 1 receptor blocker, candesartan attenuated colonic inflammation in dextran\u2010sulfate induced colitis via inhibition of madcam\u20101 expression (abstracts of the AGA Institute)","volume":"130","author":"Wada T","year":"2006","journal-title":"Gastroenterology"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725\u2010200409000\u201000007"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2012.06.055"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097193"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2015.03.017"},{"issue":"2","key":"e_1_2_12_33_1","first-page":"97","article-title":"Therapeutic effect of olmesartan medoxomile alone and in combination with sulfasalazine in experimentally ulcerative colitis model in rats","volume":"8","author":"Fatima DSA","year":"2016","journal-title":"Int J Toxicol Pharmacol Res"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016\u20105085(13)63005\u2010X"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4686"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00383\u2010016\u20103965\u20103"},{"issue":"3","key":"e_1_2_12_37_1","first-page":"355","article-title":"Orally administered angiotensin\u2010converting enzyme\u2010inhibitors captopril and isoleucine\u2010proline\u2010proline have distinct effects on local renin\u2010angiotensin system and corticosterone synthesis in dextran sulfate sodium\u2010induced colitis in mice","volume":"68","author":"Salmenkari HHM","year":"2017","journal-title":"J Physiol Pharmacol"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep27552"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.17179\/excli2021\u20103370"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201099412\u20108"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2018.4.07"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.21.6.A1322\u2010a"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016\u20105085(19)38461\u20106"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2013.11.005"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/628268"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharep.2014.12.011"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2005.03.009"},{"issue":"9","key":"e_1_2_12_48_1","first-page":"1629","article-title":"Effect of captopril on inflammatory biomarkers, oxidative stress parameters","volume":"9","author":"Manna MJ","year":"2017","journal-title":"J Pharm Sci Res"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2014.12.020"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2013.04.026"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2022.2086939"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2019.07.014"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2018.12.020"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.regpep.2007.10.004"},{"issue":"6","key":"e_1_2_12_55_1","first-page":"604","article-title":"Ameliorative effect of olmesartan medoxomil on acetic acid\u2010induced colitis in rats","volume":"8","author":"Fatima DSA","year":"2016","journal-title":"Int J Pharmaceut Clin Res"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016\u20105085(15)30091\u20103"},{"issue":"2","key":"e_1_2_12_57_1","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper HS","year":"1993","journal-title":"Lab Invest"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1995.269.1.G119"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742\u20107843.2011.00713.x"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620\u2010019\u20105474\u20104"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001912"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1093\/ecco\u2010jcc\/jjz203.546"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102020\u2010321186"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl\u20102019\u2010318512"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13099\u2010015\u20100076\u2010y"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2007.41"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.4196\/kjpp.2014.18.4.279"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000369"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjos\u20102020\u2010100115"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1177\/0023677219883319"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.4314\/tjpr.v15i10.14"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.90462.2008"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/718617"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S40107"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e318281f2e8"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.32074\/1591\u2010951X\u2010235"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11040939"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1109\/RBME.2009.2034865"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/08941939.2020.1821844"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.157.3.1261"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI19836"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00054725\u2010199811000\u201000005"},{"key":"e_1_2_12_83_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365\u20102249.2003.02268.x"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.01.007"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro\u20102016\u2010100762"}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/fcp.12935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T19:22:37Z","timestamp":1700680957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/fcp.12935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,2]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1111\/fcp.12935"],"URL":"https:\/\/doi.org\/10.1111\/fcp.12935","archive":["Portico"],"relation":{},"ISSN":["0767-3981","1472-8206"],"issn-type":[{"value":"0767-3981","type":"print"},{"value":"1472-8206","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,2]]},"assertion":[{"value":"2023-03-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-13","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-07-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}